AmundsenP.FossO. P.GodalH. C.Nitter-HaugeS.: Intravenous injections of metrizamide into human volunteers. Acta radiol. (1973) Suppl. No. 335, p. 339.
2.
BrabandH.LessmannH. D.WenkerH.: Experimentelle Untersuchungen über die Elimination und Neurotoxizität eines neuen, wasserlöslichen Kontrastmittels zur lumbosakralen Myelographie. Radiologe12 (1972), 66.
3.
CampbellR. L.CampbellJ. A.HeimburgerR. F.KalsbeckJ. E.MealeyJ.: Ventriculography and myelography with absorbable radiopaque medium. Radiology83 (1964), 286.
4.
CattellW. R.FryK.SpencerA. G.PurkissP.: Excretion urography. I. Factors determining the excretion of Hypaque. Brit. J. Radiol.40 (1967), 561.
5.
DawsonJ. B.McChesneyE. W.TellerF. F.: Excretion of metrizoate in man. Acta radiol. Diagnosis7 (1968), 502.
6.
DennebergT.: Clinical studies on kidney function with radioactive sodium diatrizoate (Hypaque®Acta med. scand. (1965) Suppl. No. 442, p. 26.
7.
DunnC. R.BerkR. N.: The pharmaco-kinetics of telepaque metabolism. The relation of blood concentration and bile flow to the rate of hepatic excretion. Amer. J. Roentgenol.114 (1972), 758.
8.
GolmanK.DahlS. G.: Absorption of labelled metrizamide, diatrizoate, inulin and water from cerebrospinal fluid to blood. A pharmacokinetic investigation in cats with normal and impaired renal function. Acta radiol. (1973) Suppl. No. 335, p. 276.
9.
HaavaldsenJ.LundeG.: The synthesis of 125I-labelled -(3-acetamido-5-N-methyl-acetamido-2,4,6-triiodobenzamido)-2-deoxy-D-gIucose. To be published in Acta chem. scand.
10.
HanssonR.LindholmT.: Elimination of Hypaque (Sodium-3,5-diacetamido-2,4,6-triiodobenzoate) and the effect of haemodialysis in anuria. Acta med. scand.174 (1963), 611.
11.
HoppeG.: Pharmakologische und toxikologische Grundlagen eines neuen trijodierten injizierbaren Kontrastmittels. Arzneimittel-Forsch.14 (1964), 291.
12.
HoppeJ. O.BrosseauA.SansoneR.: Quoted in: A summary of laboratory data on Isopaque-300. Winthrop Laboratories, New York, N.Y., May5 (1966), 20.
13.
JacobsenT. V.: Analytical Department of Nyegaard & Co. A/S, Oslo, Norway, Internal report, 1973.
14.
JohnsonC. A.VickersC.: The flask combustion technique in pharmaceutical analysis: Iodine-containing substances. J. Pharm. Pharmacol.11 (1959), 218T.
15.
JunkmannK.: Zur Pharmakologie von Röntgenkontrastmitteln. Japanese medicine in 1959; Proc. 15th Gen. Assemb. Japanese Med. Congr. 1, p. 697, (Quoted from McChesney1971).
16.
KimbelK. H.BörnerW.: Über den Verbleib von 131J-markiertem Urografin im Körper. Naunyn-Schmiedeberg's Arch. exp. path. Pharmak.226 (1955), 262.
LuomaP.: Anatomical and physiological considerations of the biliary tract. Acta pharmacol. (Kbh.)29 (1971), 7.
20.
McChesneyE. W.: Routes and rates of excretion of radiocontrast agents. In:Radiocontrast agents. First edition, p. 335, Pergamon Press Ltd., London1971.
21.
McChesneyE. W.HoppeJ. O.: Studies of the tissue distribution and excretion of sodium diatrizoate in laboratory animals. Amer. J. Roentgenol.78 (1957), 137.
22.
MossA. A.AmbergJ. R.JonesScott R.: Relationship of bile salts and bile flow to biliary excretion of iopanoic acid. Invest. Radiol.7 (1972), 11.
23.
OlssonO.: Excretion of sodium metrizoate through the liver during urography. Acta radiol. Diagnosis11 (1971), 85.
24.
SalvesenS.: Suboccipital injection of metrizamide to anaesthetized and unanaesthetized rabbits. Acta radiol. (1973) Suppl. No. 335, p. 93.
25.
SchankerL. S.: Concentrative transfer of an organic cation from blood into bile. Biochem. Pharmacol.11 (1962), 253.
26.
SchankerL. S.Passage of drugs across body membranes. Pharmacol. Rev.14 (1962), 501.
27.
SchlungbaumW.: Verteilung, Ausscheidung und Resorption nierengängiger, mit J131-markierter Röntgenkontrastmittel. Fortschr. Röntgenstr.96 (1962), 795.
28.
SchlungbaumW.BillionH.: Untersuchungen der Verteilung von radioaktivem Urografin im menschlichen Organismus. Klin. Wschr.34 (1956), 45.
29.
SkalpeI. O.TorbergsenT.AmundsenP.PresthusJ.: Lumbar myelography with metrizamide. Acta radiol. (1973) Suppl. No. 335, p. 367.
30.
SmithR. L.: The biliary excretion and enterohepatic circulation of drugs and other organic compounds. Fortschr. Arzneimittelforsch.9 (1966), 299.
31.
SperberI.SperberG.: Hepatic excretion of radiocontrast agents. In:Radiocontrast agents. First edition, p. 165. Pergamon Press Ltd., London1971.
32.
von ToschR.: Untersuchungen über die Resorption von J131-markiertem Gastrografin aus dem Magen-Darm-Kanal. Fortschr. Röntgenstr.90 (1964), 189.
33.
van WaesP. F. G. M.: High-dose urography in oliguric and anuric patients. Excerpta Medica. Amsterdam1972.